Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.
Holowiecka-Goral
Aleksandra
A
Department of Hematology and BMT, Silesian Medical University, Katowice, Poland. alexholow@wp.pl
Hołowiecki
Jerzy
J
Giebel
Sebastian
S
Stella-Holowiecka
Beata
B
Krawczyk-Kulis
Małgorzata
M
Kos
Kinga
K
Lehmann-Kopydłowska
Agata
A
Dudzinski
Marek
M
Hałasz
Magdalena
M
Preisner
Witold
W
Cioch
Maria
M
Piszcz
Jarosław
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D003561:Cytarabine / Q000008:administration & dosage*; D004337:Drug Carriers; D005260:Female; D006801:Humans; D008081:Liposomes; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011044:Poland; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction; D016896:Treatment Outcome; D055815:Young Adult
D004337:Drug Carriers; D008081:Liposomes; D003561:Cytarabine